 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Piper Sandler Sticks to Its Buy Rating for Minerva Surgical (UTRS)

SANTA CLARA, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women's health company focused on solutions to meet the distinct...

Minerva Surgical Reports Third Quarter 2023 Financial Results

Shares of Minerva Surgical, Inc. (NASDAQ:UTRS  Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $3.18, but opened at $3.09. Minerva Surgical shares...

Minerva Surgical (NASDAQ:UTRS) Shares Gap Down to $3.18

Minerva Surgical (NASDAQ:UTRS Get Free Report) and West Pharmaceutical Services (NYSE:WST Get Free Report) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, earnings, analyst recommendations, profitability, ...

Minerva Surgical (NASDAQ:UTRS) versus West Pharmaceutical Services (NYSE:WST) Financial Review

Minerva Surgical, Inc. (UTRS) Q2 2023 Earnings Call Transcript

Minerva Surgical GAAP EPS of -$0.05 beats by $0.04, revenue of $13.4M misses by $0.52M

Minerva Surgical (NASDAQ:UTRS  Get Free Report) and Inari Medical (NASDAQ:NARI  Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, profitability, analyst ...

Analyzing Minerva Surgical (NASDAQ:UTRS) & Inari Medical (NASDAQ:NARI)

Minerva Surgical (NASDAQ:UTRS Free Report) and AngioDynamics (NASDAQ:ANGO Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, earnings, risk, institutional ownership...

Analyzing Minerva Surgical (NASDAQ:UTRS) and AngioDynamics (NASDAQ:ANGO)

Minerva Surgical, Inc. (NASDAQ:UTRS  Free Report) saw a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 475,400 shares, a decrease of 23.9% from the May 31st total of 624,700 shares. Approximately 3.1% of the shares of the stock ...

Short Interest in Minerva Surgical, Inc. (NASDAQ:UTRS) Declines By 23.9%

AngioDynamics (NASDAQ:ANGO  Free Report) and Minerva Surgical (NASDAQ:UTRS  Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, ...

Critical Comparison: Minerva Surgical (NASDAQ:UTRS) versus AngioDynamics (NASDAQ:ANGO)

Minerva Surgical, Inc. engages in the research, development, manufacture, and commercialization of invasive solutions for uterine healthcare needs of women. It offers therapeutic devices for abnormal uterine bleeding treatment. The company was founded by Csaba Truckai in 2008 and is headquartered in Santa Clara, CA.

Watchers	916
52-Wk Low	$1.55
52-Wk High	$14.00

Market Cap	$15.36M
Volume (M)	8,171.00
52-Wk High	$14.00
52-Wk Low	$1.55

Current Price	$1.66
Prev Close	$1.73
Open	$1.64
Dividend Yield	0.00%
50-Day Moving Average	$2.92
Beta	0.00
Avg. Volume	19,319.27
PE Ratio	-0.07

52-Week High	$14.00
52-Week Low	$1.55
Market Capitalization	$15.36M
EPS	-$23.71
Price to Book	0.04
Revenue Per Employee	$297,086.21
Enterprise Value/EBITDA	-1.33

UTRS Minerva Surgical Inc

About

Feed

News

Earnings

Fundamentals